Correlation Between Salesforce and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Salesforce and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Nuvectis Pharma, you can compare the effects of market volatilities on Salesforce and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Nuvectis Pharma.
Diversification Opportunities for Salesforce and Nuvectis Pharma
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Salesforce and Nuvectis is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Salesforce i.e., Salesforce and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Salesforce and Nuvectis Pharma
Considering the 90-day investment horizon Salesforce is expected to generate 0.37 times more return on investment than Nuvectis Pharma. However, Salesforce is 2.7 times less risky than Nuvectis Pharma. It trades about 0.08 of its potential returns per unit of risk. Nuvectis Pharma is currently generating about -0.01 per unit of risk. If you would invest 19,562 in Salesforce on August 24, 2024 and sell it today you would earn a total of 14,640 from holding Salesforce or generate 74.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salesforce vs. Nuvectis Pharma
Performance |
| Timeline |
| Salesforce |
| Nuvectis Pharma |
Salesforce and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Nuvectis Pharma
The main advantage of trading using opposite Salesforce and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |